Navigation Links
Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronie's Disease
Date:10/11/2010

ase II clinical trials for Peyronie's disease; the number of men affected by Peyronie's disease; and products in development for Dupuytren's contracture, and Frozen Shoulder syndrome., overactive bladder, pain, hormone replacement and urologic disease.  All statements other than statements of historical facts contained in this release, including but not limited to, statements regarding future expectations, plans and prospects for the Company, statements regarding forward-looking financial information and other statements containing the words "believe," "appears," "may," "could," "will," "estimate," "continue," "anticipate," "intend," "should," "plan," "expect," and similar expressions, as they relate to the Company, constitute forward-looking statements. Actual results may differ materially from those reflected in these forward-looking statements due to various factors, including further evaluation of clinical data, results of clinical trials, the performance of third-party service providers, decisions by regulatory authorities regarding whether or when to proceed to the next phase of clinical trials, general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries and those discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2009 under the heading "Risk Factors," and in Auxilium's Quarterly Report on Form 10-Q for the period ended June 30, 2010, which are on file with the Securities and Exchange Commission (the "SEC") and may be accessed electronically by means of the SEC's home page on the Internet at http://www.sec.gov or by means of the Company's home page on the Internet at http://www.auxilium.com under the heading "For Investors -- SEC Filings." There may be additional risks that the Company does not presently know or that the Company currently believes are immaterial which could also cause actu
'/>"/>
SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
3. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
6. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
7. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
8. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
9. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
10. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
11. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014 Nuclear medicine ... 2015. Radiopharmaceuticals/ Nuclear are drugs that ... imaging field to diagnose and treat diseases. ... Increasing awareness for radiopharmaceuticals, and ready availability of ... market. Furthermore, increased public awareness and use of ...
(Date:9/23/2014)... 23, 2014 FDNA ... d,une série de démonstrations personnelles   ... domaine de l,analyse de la dysmorphologie assistée ... n° 1035 lors de la réunion ASHG 2014, qui ... , en Californie. FDNA présentera la ...
(Date:9/23/2014)... Dans les secteurs ... ferroviaire ou encore l,énergie, les machines, de ... à leurs données. Ces données de masse ... cœur des voitures, trains, avions, appareils médicaux… ... le nombre de machines connectées d,ici 2020. ...
Breaking Medicine Technology:Global Nuclear Medicine Market - Growth, Trends & Forecasts (2014-2019) 2FDNA exposera sa solution Face2Gene intégrée en ligne avec London Medical Databases (LMD) à l'ASHG 2014 2FDNA exposera sa solution Face2Gene intégrée en ligne avec London Medical Databases (LMD) à l'ASHG 2014 3Altran transforme le big data du monde industriel en nouveau business 2
... ThermalTherapeutic Systems, Inc. (TTS), maker of portable ... F.H. Smith as President and Chief Executive Officer. Mr. ... operational executive in the high-tech sector, focused on biotech, ... F. Vennare will transition to the role of Executive ...
... 2011 Bay Sleep, the West Coast,s largest and ... its newest, state-of-the-art sleep clinic in Oakland, California.  Located ... Sleep,s 16th clinic open for business. Services include sleep ... dispensing CPAP and other therapies for patients diagnosed with ...
Cached Medicine Technology:ThermalTherapeutic Systems, Inc. Names Gardiner F. H. Smith, President and Chief Executive Officer 2Bay Sleep Clinic Continues Growth in California and Beyond 2
(Date:9/23/2014)... 23, 2014 Grinnell Mutual seeks ... projects in the Midwest. Working Together Making It ... non-profit organizations with projects positively impacting their communities. ... marketplace make their communities a better places,” said ... Community Relations Barb Baker. “Their leadership—as coaches, as ...
(Date:9/23/2014)... News) -- The number of ,rogue, wholesale distributors ... so doctors need to be vigilant when purchasing ... Tuesday. In a statement, the agency said ... launched a program to educate doctors and other ... purchasing procedures. The program aims to protect patients ...
(Date:9/23/2014)... A national report showing the benefits of ... for providing Medicaid services was released today by ... report, "Why Congress Must Save the Medicaid Primary ... to Ensure Access to Life-Saving Primary Care Will ... Medicaid patients, access to internists and pediatricians (and ...
(Date:9/23/2014)... September 23, 2014 Trevera provides ... market. Included are Oracle Managed Services , ... supports all versions of Oracle E-Business Databases ... , Trevera has announced a significant enhancement ... need help with their software technology management, project ...
(Date:9/23/2014)... 2014 SOURCE: Solutions from Our ... were made to Rimidi Diabetes and ... with business solutions to challenges faced by patients and ... collaboration between The Hitachi Foundation, Village ... entrepreneurs with the investment capital, mentoring, and support needed ...
Breaking Medicine News(10 mins):Health News:Grinnell Mutual Invites Submissions for Innovative, Collaborative Local Projects in Its Second Annual Working Together Making It Better Promotion 2Health News:Unless Congress acts, patients may soon lose access to primary care 2Health News:Unless Congress acts, patients may soon lose access to primary care 3Health News:Trevera, Inc adds Management Support to Services 2Health News:Trevera, Inc adds Management Support to Services 3Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 2Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 3Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 4Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 5
... Cardiac Science (Nasdaq: CSCX ), a ... informatics products, today announced today that it will present ... at the Ritz Carlton Laguna Nigel. John Hinson, president ... strategy and recent financial results during the Company,s presentation ...
... & Sullivan to Host Quarterly Analyst Briefing on ... The Chemicals Group at Frost & Sullivan ... Analyst Briefing Presentation on Medical Trends Impacting the ... Thursday, 26 February, 2009 at 3 p.m. GMT.(Logo: ...
... 17 Microscopic insects called dust mites are the leading cause of ... indoor allergens are pet dander and dust mold. Dust mites are ... carpets by the tens of millions. There can be as many ... written by Jay DeFoore titled " Is your ...
... Arkansas-based electronic medical transcription and document management software provider, will ... , ... Little Rock, AR (PRWeb) ... document management software provider eMedDox (formerly Health Data Services, LLC) ...
... getting pharmaceutical companies more directly involved in helping patients in need ... the YourRxCard free prescription drug card. The company also announced new ... , privately funded by Group Net LLC. , ... ...
... doctors, pharmacists and other healthcare professionals a free, unique medical ... For posting occasional prescription drug information and insight on PrescriptionDrug-Info.com, ... inbound links to the URL of their choice. , ... ...
Cached Medicine News:Health News:Cardiac Science to Present at the Roth 21st Annual OC Growth Stock Conference 2Health News:Cardiac Science to Present at the Roth 21st Annual OC Growth Stock Conference 3Health News:Frost & Sullivan Helps You Know Your End-Market: Medical Trends Impacting the Chemicals and Materials Markets 2Health News:Frost & Sullivan Helps You Know Your End-Market: Medical Trends Impacting the Chemicals and Materials Markets 3Health News:Are You Really Sleeping on Clean Bedsheets? 2Health News:New Website Coming Soon for Electronic Medical Transcription Company 2Health News:Patient Savings on Prescription Drugs Reach Record High for 2008, Goal Announced for 2009 2Health News:Patient Savings on Prescription Drugs Reach Record High for 2008, Goal Announced for 2009 3Health News:Patient Savings on Prescription Drugs Reach Record High for 2008, Goal Announced for 2009 4Health News:Patient Savings on Prescription Drugs Reach Record High for 2008, Goal Announced for 2009 5Health News:Patient Savings on Prescription Drugs Reach Record High for 2008, Goal Announced for 2009 6Health News:Prescription Drug Information Site Offers Free Medical Marketing Opportunity to Healthcare Professionals 2Health News:Prescription Drug Information Site Offers Free Medical Marketing Opportunity to Healthcare Professionals 3
The Bledsoe Flatform Boot is designed with a flat innersole for procedures where toe dorsiflexion is not permissible....
The Bledsoe Achilles Boot saves time by eliminating casting series required to stretch the achilles tendon during rehab....
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
... Bauerfeind™ AchilloTrain® The viscoelastic insert runs ... application of pressure and targeted intermittent ... reduction of painful irritation of the ... integrated viscoelastic heel wedge (raises heel ...
Medicine Products: